Literature DB >> 7888098

Growth factor receptors in amyotrophic lateral sclerosis.

A Adem1, J Ekblom, P G Gillberg.   

Abstract

The regional distribution of nerve growth factor (NGF) and insulin-like growth factor-1 (IGF-1) receptors in human spinal cords from controls and amyotrophic lateral sclerosis (ALS) patients was studied by quantitative autoradiography. High-affinity nerve growth factor receptors were found to be distributed to a similar extent within the various segments of the human spinal cord and predominantly within the substantia gelatinosa of the dorsal horn, whereas no significant binding could be detected in the motor-neuron areas. A similar pattern of binding was obtained in the ALS spinal cords. Moreover, no reexpression of NGF receptors could be demonstrated in the motor-neuron areas of ALS spinal cords. When comparing 125I-IGF-1 binding in the different spinal levels of normal spinal cord, the same distribution pattern was found in which the binding was highest in the central canal > dorsal horn > ventral horn > white matter. In the ALS cases, although a general upregulation of IGF-1 receptors was observed throughout the spinal cord, significant increases were observed in the cervical and sacral segments compared to controls. The cartography of IGF-1 receptors in the normal spinal cord as well as the change of these receptors in diseased spinal cord may be of importance in future treatment strategies of ALS.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7888098     DOI: 10.1007/BF02816121

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  35 in total

1.  Increased binding of 3H-L-deprenyl in spinal cords from patients with amyotrophic lateral sclerosis as demonstrated by autoradiography.

Authors:  S M Aquilonius; S S Jossan; J G Ekblom; H Askmark; P G Gillberg
Journal:  J Neural Transm Gen Sect       Date:  1992

2.  Gene transfer and molecular cloning of the rat nerve growth factor receptor.

Authors:  M J Radeke; T P Misko; C Hsu; L A Herzenberg; E M Shooter
Journal:  Nature       Date:  1987 Feb 12-18       Impact factor: 49.962

Review 3.  Physiology of nerve growth factor.

Authors:  H Thoenen; Y A Barde
Journal:  Physiol Rev       Date:  1980-10       Impact factor: 37.312

4.  NGF-mediated increase of choline acetyltransferase (ChAT) in the neonatal rat forebrain: evidence for a physiological role of NGF in the brain?

Authors:  H Gnahn; F Hefti; R Heumann; M E Schwab; H Thoenen
Journal:  Brain Res       Date:  1983-07       Impact factor: 3.252

5.  Patient resistance and prognosis in amyotrophic lateral sclerosis.

Authors:  D W Mulder; F M Howard
Journal:  Mayo Clin Proc       Date:  1976-09       Impact factor: 7.616

6.  Re-expression of Nerve Growth Factor Receptor after Axonal Injury Recapitulates a Developmental Event in Motor Neurons: Differential Regulation when Regeneration is Allowed or Prevented.

Authors:  S J Wood; J Pritchard; M V Sofroniew
Journal:  Eur J Neurosci       Date:  1990       Impact factor: 3.386

7.  Macroglobulinemia with peripheral neuropathy simulating motor neuron disease.

Authors:  L P Rowland; R Defendini; W Sherman; A Hirano; M R Olarte; N Latov; R E Lovelace; K Inoue; E F Osserman
Journal:  Ann Neurol       Date:  1982-05       Impact factor: 10.422

8.  Insulin-like growth factor I gene expression is induced in astrocytes during experimental demyelination.

Authors:  S Komoly; L D Hudson; H D Webster; C A Bondy
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

9.  Insulin-like growth factor II (IGF II) in human brain: regional distribution of IGF II and of higher molecular mass forms.

Authors:  G K Haselbacher; M E Schwab; A Pasi; R E Humbel
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

10.  Receptors for insulin-like growth factors I and II: autoradiographic localization in rat brain and comparison to receptors for insulin.

Authors:  M A Lesniak; J M Hill; W Kiess; M Rojeski; C B Pert; J Roth
Journal:  Endocrinology       Date:  1988-10       Impact factor: 4.736

View more
  3 in total

Review 1.  Insulin-like growth factor-I is a differentiation factor for postmitotic CNS stem cell-derived neuronal precursors: distinct actions from those of brain-derived neurotrophic factor.

Authors:  Y Arsenijevic; S Weiss
Journal:  J Neurosci       Date:  1998-03-15       Impact factor: 6.167

2.  Preserved expression of fibroblast growth factor (FGF)-2 and FGF receptor 1 in brain and spinal cord of amyotrophic lateral sclerosis patients.

Authors:  Susanne Petri; Klaus Krampfl; Kerstin Kuhlemann; Reinhard Dengler; Claudia Grothe
Journal:  Histochem Cell Biol       Date:  2008-12-19       Impact factor: 4.304

Review 3.  Insulin-like growth factor-I for the treatment of amyotrophic lateral sclerosis.

Authors:  Stacey A Sakowski; Adam D Schuyler; Eva L Feldman
Journal:  Amyotroph Lateral Scler       Date:  2009-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.